Delivery Order SPE2DR25D2014-SPE2DR26FA2M9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,467.96 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. The contract is a firm fixed price delivery order with no set-aside designation, issued on December 4, 2025, with an ultimate completion date of December 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $2,642.36 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This delivery order was issued on October 28, 2025, with an ultimate completion date of October 29, 2025, and represents a firm fixed-price, non-set-aside procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,517.26 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a delivery order valued at $4,493.20 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities. This order, issued on August 13, 2025, with completion targeted for August 14, 2025, represents a firm fixed-price delivery under a non-set-aside competitive procurement. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,675.25 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance to be completed by January 14, 2026, and fulfillment occurring at the awardee's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,899.35 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 25, 2025, one day after the award date. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,217.64 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This is a firm fixed-price, non-set-aside contract awarded on January 9, 2026, with an ultimate completion date of January 12, 2026. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order represents a task order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency has awarded a delivery order valued at $1,362.40 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure, with an ultimate completion date of September 29, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,969.72 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order was placed on October 22, 2025, with an ultimate completion date of October 23, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit with a ceiling value of $2,185.04. This firm fixed-price delivery order was awarded on December 30, 2025, with an ultimate completion date of December 31, 2025, and represents a non-set-aside competitive award. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA2M9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,448.95 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. This non-competitive, firm fixed-price delivery order was awarded on January 14, 2026, with an ultimate completion date of January 15, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract demonstrates the company's versatility in fulfilling federal medical supply needs through competitive procurement mechanisms, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 1/13/26 |